BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10415006)

  • 1. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous.
    Bachmann MF; Köhler G; Ecabert B; Mak TW; Kopf M
    J Immunol; 1999 Aug; 163(3):1128-31. PubMed ID: 10415006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
    Khattri R; Auger JA; Griffin MD; Sharpe AH; Bluestone JA
    J Immunol; 1999 May; 162(10):5784-91. PubMed ID: 10229811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.
    Tivol EA; Boyd SD; McKeon S; Borriello F; Nickerson P; Strom TB; Sharpe AH
    J Immunol; 1997 Jun; 158(11):5091-4. PubMed ID: 9164923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease.
    Chikuma S; Bluestone JA
    Eur J Immunol; 2007 May; 37(5):1285-9. PubMed ID: 17429849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice.
    Hwang KW; Sweatt WB; Mashayekhi M; Palucki DA; Sattar H; Chuang E; Alegre ML
    J Immunol; 2004 Nov; 173(9):5415-24. PubMed ID: 15494488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.
    Chambers CA; Sullivan TJ; Allison JP
    Immunity; 1997 Dec; 7(6):885-95. PubMed ID: 9430233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
    Chambers CA; Kuhns MS; Egen JG; Allison JP
    Annu Rev Immunol; 2001; 19():565-94. PubMed ID: 11244047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
    Tivol EA; Borriello F; Schweitzer AN; Lynch WP; Bluestone JA; Sharpe AH
    Immunity; 1995 Nov; 3(5):541-7. PubMed ID: 7584144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: CTLA-4 on effector T cells inhibits in trans.
    Corse E; Allison JP
    J Immunol; 2012 Aug; 189(3):1123-7. PubMed ID: 22753941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CTLA-4 in regulating Th2 differentiation.
    Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
    J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of CTLA-4 in regulation of resting memory versus naive CD4 T cell activation.
    Metz DP; Farber DL; Taylor T; Bottomly K
    J Immunol; 1998 Dec; 161(11):5855-61. PubMed ID: 9834064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 regulates tolerance induction and T cell differentiation in vivo.
    Walunas TL; Bluestone JA
    J Immunol; 1998 Apr; 160(8):3855-60. PubMed ID: 9558090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.
    Tivol EA; Gorski J
    J Immunol; 2002 Aug; 169(4):1852-8. PubMed ID: 12165509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells.
    Emoto M; Mittrücker HW; Schmits R; Mak TW; Kaufmann SH
    J Immunol; 1999 May; 162(9):5094-8. PubMed ID: 10227978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 alphabeta T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria.
    Schlotmann T; Waase I; Jülch C; Klauenberg U; Müller-Myhsok B; Dietrich M; Fleischer B; Bröker BM
    J Infect Dis; 2000 Jul; 182(1):367-70. PubMed ID: 10882627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
    Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
    J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transgenic mouse strain with antigen-specific T cells (RAG1KO/sf/OVA) demonstrates that the scurfy (sf) mutation causes a defect in T-cell tolerization.
    Zahorsky-Reeves JL; Wilkinson JE
    Comp Med; 2002 Feb; 52(1):58-62. PubMed ID: 11900414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
    Waterhouse P; Penninger JM; Timms E; Wakeham A; Shahinian A; Lee KP; Thompson CB; Griesser H; Mak TW
    Science; 1995 Nov; 270(5238):985-8. PubMed ID: 7481803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.
    Homann D; Dummer W; Wolfe T; Rodrigo E; Theofilopoulos AN; Oldstone MB; von Herrath MG
    J Virol; 2006 Jan; 80(1):270-80. PubMed ID: 16352552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.